Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Interaction of family history, physical activity and environmental factors in the risk for the development of prostate cancer Omar Abdel-Rahman Avicenna Oncology Center PLCO Sep 25, 2018 PLCO-398
Interpretability of machine learning based prediction models for ovarian cancer classification using PLCO dataset Khyati Shah Liverpool John Moores University, UK PLCO May 20, 2020 PLCO-628
Interpretable AI prediction of prostate tumor staging Matthias Weidemüller Universität Heidelberg PLCO Jan 18, 2022 PLCO-897
Interpretable AI prediction of prostate tumor staging Björn Ommer Ludwig Maximilian University of Munich (Machine Vision & Learning Group) PLCO Apr 25, 2022 PLCOI-970
Interpretable Artificial Intelligence to select patients that will benefit from lung cancer screening Jean-Emmanuel Bibault Stanford University PLCO Mar 5, 2020 PLCO-594
Interpretable Graph Convolutional Networks with CPC features for Whole Slide Histology Classification Faisal Mahmood Brigham and Women's Hospital NLST Oct 29, 2019 NLST-592
Interpretable machine learning models for lung cancer screening Cynthia Rudin Duke NLST Aug 2, 2017 NLST-332
Interrelationship between Sexually Transmitted Infections, Genetic Variation in MSR1 and Other Inflammation Genes, and Prostate Cancer (CGEMS Value-Added Study) Wen-Yi Huang NCI, DCEG, OEEB PLCO Oct 15, 2007 2007-0045
Intrafamilial Concordance of Age of Clinical Manifestations of Prostate Cancer Peter Tishler Channing Laboratory PLCO Jul 1, 2006 2006-0251
Invasive Procedures and Associated Complications Following Initial Lung Cancer Screening in a National Cohort of Veterans. Eduardo Nunez Boston University NLST Jul 26, 2021 NLST-822
Investigating intratumoral and microenvironmental heterogeneity through computational pathology approaches Eliezer Van Allen Dana-Farber Cancer Institute PLCO Feb 10, 2025 PLCOI-1819
Investigating Lung Cancer Screening Guidelines Chi-Fu Yang Massachusetts General Hospital PLCO Jan 10, 2025 PLCO-1785
Investigating multi-modal signatures of clinical outcome to immunotherapy in renal cell carcinoma Sachet Shukla Dana-Farber Cancer Institute PLCO Oct 22, 2020 PLCO-679
Investigating polygenic prediction of cancer risk and cancer-related phenotypes Gil McVean Genomics plc PLCO Nov 22, 2022 PLCO-1106
Investigating Potential of Ethnicity Information Embedded in Medical Images Rasika Rajapakshe BC Cancer, part of the Provincial Health Services Authority NLST Jun 17, 2024 NLST-1264
Investigating pre-diagnostic blood proteomic profiles in relation to pancreatic ductal adenocarcinoma risk Ting Zhang National Cancer Institute PLCO Jun 12, 2025 2025-0006
Investigating Survival Dynamics in Oncological Patients Through Machine Learning and Deep Learning Approaches Yukti Tripathi Amity University NLST Feb 6, 2025 NLST-1386
Investigating the agreement of the composition and time spent in different physical activities derived from accelerometer data captured at different sensor locations Malcolm Granat University of Salford IDATA Oct 21, 2021 IDATA-49
Investigating the (cost-)effectiveness of implementing lung cancer screening policies in the province of Ontario, Canada, using microsimulation modeling. Kevin ten Haaf Erasmus MC NLST Aug 20, 2014 NLST-87
Investigating the Protective Role of Breastfeeding Against Breast Cancer Suhad Ali Research Institute McGill University Health Centre PLCO Aug 9, 2024 PLCO-1643